OUTLOOK THERAPEUTICS, INC. Share Price Nasdaq
Equities
US68235M1053
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | 9.53M 796M | Capitalization | 198M 16.52B |
---|---|---|---|---|---|
Net income 2024 * | -121M -10.11B | Net income 2025 * | -64M -5.35B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 20.7 x |
P/E ratio 2024 * |
-1.68
x | P/E ratio 2025 * |
-3.79
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 63.78% |
Latest transcript on OUTLOOK THERAPEUTICS, INC.
Managers | Title | Age | Since |
---|---|---|---|
C. Trenary
CEO | Chief Executive Officer | 66 | 07/21/07 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15/15/15 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 19/23/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Randy Thurman
CHM | Chairman | 74 | 13/18/13 |
Kurt Hilzinger
BRD | Director/Board Member | 63 | 11/15/11 |
C. Trenary
CEO | Chief Executive Officer | 66 | 07/21/07 |
1st Jan change | Capi. | |
---|---|---|
+22.15% | 46.56B | |
+44.98% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
+20.42% | 28.18B | |
-6.35% | 28.1B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |